Why the study?
Does instillation of triamcinolone hexacetonide via subxiphoid pericardiotomy improve outcomes in maintenance hemodialysis patients with intractable uremic pericardial effusion?
Does instillation of triamcinolone hexacetonide via subxiphoid pericardiotomy improve outcomes in maintenance hemodialysis patients with intractable uremic pericardial effusion?
Local instillation of triamcinolone hexacetonide via subxiphoid pericardiotomy appears to be an effective and safe treatment for intractable uremic pericardial effusion in hemodialysis patients.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for triamcinolone instillation in uremic pericardial effusion; larger controlled trials needed before clinical adoption.
Seven maintenance hemodialysis patients suffering from intractable uremic pericardial effusion were treated with instillation of a non-absorbable steroid, triamcinolone hexacetonide, into the pericardial sac via a large-bore catheter. The latter was placed under direct vision by subxiphoid pericardiotomy. All patients responded to the treatment while complications of the procedure were few and minor.
No takes yet. Share an insight, caveat, or question.
Popli et al. (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: